Alnylam Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Alnylam Pharmaceuticals Inc
CIK #0001178670
EDGAR Form CIK 2011 - 2025
10-K [0001178670]
10-Q [0001178670]
3 [0001178670]
4 [0001178670]
5 [0001178670]
8-K [0001178670]
SC 13G [0001178670]
Form 13D/13G Filer Form 13D/13G Subject Filed
Capital Research Global Investors Alnylam Pharmaceuticals Inc [2025-02-13]
Capital World Investors Alnylam Pharmaceuticals Inc [2022-09-09]
Price T Rowe Associates Inc /MD/ Alnylam Pharmaceuticals Inc [2022-02-14]
Baillie Gifford & Co Alnylam Pharmaceuticals Inc [2020-02-03]
Price T Rowe Associates Inc /MD/ Alnylam Pharmaceuticals Inc [2017-12-11]
BlackRock Inc Alnylam Pharmaceuticals Inc [2017-01-30]
Dodge & Cox Alnylam Pharmaceuticals Inc [2016-12-09]
Vanguard Group Inc Alnylam Pharmaceuticals Inc [2016-02-10]
BlackRock Inc Alnylam Pharmaceuticals Inc [2016-01-28]
Sanofi Alnylam Pharmaceuticals Inc [2014-03-05]
View All
Form 3/4/5 Subject 2011 - 2025
Alnylam Pharmaceuticals Inc
Bonney Michael W
Greenstreet Yvonne
Poulton Jeffrey V.
Fitzgerald Kevin Joseph
Tanguler Tolga
Garg Pushkal
Ausiello Dennis A
Sigal Charles Elliott
Bertozzi Carolyn R
Brandicourt Olivier
Hamburg Margaret A
Kellogg Peter N
Pyott David E I
Reitan Colleen F
Schulman Amy W
Hesslein Robert W.
Sharp Phillip A
Franchini Indrani Lall
Vaishnaw Akshay
Fanucci Marsha
Paul Steven M
Maraganore John
Keating Laurie
Greene Barry E
Schimmel Paul
Soni Manmeet Singh
Sanofi
Mason Michael
Clarke John K
Starr Kevin P
Gros David-Alexandre C
Regulus Therapeutics Inc.
Reid Laurence
Dzau Victor J
Novartis Pharma AG
Novartis AG
Terms | Privacy | Guide
tony@aum13f.com